Medscape Medical NewsAll articles

ALPHAPOINT IMAGING SOFTWARE

RADLOGICS, INC. • Radiology • 04/13/2012

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The AlphaPoint Imaging Software is an assistive tool designed to enhance the analysis of CT chest images for medical professionals by utilizing segmentation and Hounsfield unit-based algorithms to identify and quantify various substances. It integrates with PACS via DICOM, processing images to produce preliminary findings reports that users can review, modify, and finalize, thereby supporting but not replacing clinical interpretation.

Summary

The AlphaPoint Imaging Software, developed by RadLogics, Inc., is designed to assist medical professionals in the review, analysis, and interchange of CT chest images. It functions as an application framework that integrates with Picture Archiving and Communication Systems (PACS) using the DICOM standard. The software retrieves imaging studies from PACS, processes the image data using specialized applications, and employs segmentation and Hounsfield measurement algorithms. These algorithms identify and measure various attributes within the images, and can also designate specific slices as reference images for detected findings. The core scientific principle behind AlphaPoint's analysis is the use of Hounsfield units to differentiate and indicate various substances such as air, lung tissue, soft tissue, fat, water, and different fluids like transudate, exudate, and blood, as well as muscle and bone. After processing, the system formats the results into a Preliminary Findings Report, which is then sent back to PACS. Importantly, AlphaPoint is intended as an assistive tool and not for primary diagnostic interpretation. Users have the capability to review, verify, and correct the system's automated findings before generating a final report, ensuring clinical oversight. The software is built using C++, C#, and Matlab.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

CT Chest ImagesImage AnalysisSegmentationHounsfield MeasurementDICOMPACS IntegrationPreliminary Findings ReportSubstance IndicationMedical Imaging SoftwareAssistive Tool

Device Metadata

Submission Number
K120161
Company
RADLOGICS, INC.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Analysis
AI Subclass
quantification/feature localization

Relevant Clinical Questions

  • Q1. How does the software's segmentation algorithm handle variations in image quality or atypical anatomical structures in CT chest scans?; What is the range of accuracy and sensitivity of the Hounsfield unit measurements for differentiating between similar density substances (e.g., transudate vs. exudate)?; Can the "Preliminary Findings Report" be customized by users to highlight specific types of findings or integrate with existing clinical reporting workflows?; How does the system address potential biases in its algorithms, and what validation was performed on diverse patient populations referenced in its testing protocols?; What are the computational requirements and processing times for typical CT chest studies, particularly when multiple analytical applications within AlphaPoint are activated?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score5/100
SBOM Evidence⚠ Not mentioned in summary
Cyber Risk Assessment⚠ Not mentioned in summary
Postmarket Plan⚠ Not mentioned in summary
§524B ApplicableNo

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(algorithm, bias)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials
- Not detected
HBOMHardware Bill of Materials
- Not detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials
- Not detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM detected in AI-generated device summary.

• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, SaaSBOM, HBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
ALPHAPOINT IMAGING SOFTWARE - RADLOGICS, INC. | ESL FDA AI Device Intelligence